Head of Investor Relations
Prothena Corp Public Ltd Co (PRTA)Equibles does not estimate personal net worth.
Mark Johnson is recorded as Head of Investor Relations at Prothena Corp Public Ltd Co (PRTA). Mark Johnson has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Prothena Corp Public Ltd Co on September 16, 2026. Prothena Corp Public Ltd Co is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Prothena Corp Public Ltd Co includes Gene Kinney (CEO and Board Member), Lars G. Ekman (Chairman and Board Member), Brandon S. Smith (COO and Board Member) and 7 others.
“So, you know, I think Protea has been long known as being, you know, really good innovators at coming up with new approaches in the extracellular space for protein dysregulation.”
“Good afternoon, everyone, and welcome to today's call to review Prothena's business progress, fourth quarter and full year 2025 financial results, and 2026 financial guidance.”
“In addition, we are using supplemental slides, which are available on the event and presentation section of our investor relations website. On today's call, Dr. Gene Kinney, our president and chief executive officer, will provide opening remarks, including an overview of Protena's corporate and development strategy.”
Biotechnology · Healthcare
Head of Investor Relations
